Dnaprint Genomics News Today

DNAPrint Genomics (OTCMKTS:DNAG – Get Rating) and Absci (NASDAQ:ABSI – Get Rating) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, risk, earnings, institutional ownership, dividends, valuation and profitability. Volatility and Risk DNAPrint Genomics has a beta of -0.67, suggesting […]